Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.05
Bid: 4.96
Ask: 5.08
Change: 0.00 (0.00%)
Spread: 0.12 (2.419%)
Open: 5.05
High: 5.05
Low: 5.05
Prev. Close: 5.05
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Final Results

17 Sep 2008 08:37

RNS Number : 6192D
Seeing Machines Limited
17 September 2008
 



17 September 2008

Seeing Machines Limited

("Seeing Machines")

NOTICE OF FINAL RESULTS

Seeing Machines (AIM: SEE), a leading developer of advanced computer based imaging software systems, will announce results for the year ended 30 June 2008 on Tuesday, 23 September 2008. 

Meetings for analysts and press will take place on the day and for further information please contact:

Parkgreen Communications Ltd

Ben Knowles

+44 (0) 20 7933 8788

ben.knowles@parkgreenmedia.com

Paul McManus

+44 (0) 20 7933 8787

paul.mcmanus@parkgreenmedia.com

Enquires:

 

Seeing Machines Limited

Nick Cerneaz, CEO

+61 (0) 2 6125 6501

www.seeingmachines.com

Grant Thornton UK LLP

Fiona Owen

+44 (0) 20 7383 5100

SVS Securities plc

Peter Manfield

+44 (0) 20 7638 5600

  Notes to editors:

About Seeing Machines

Seeing Machines is an award winning Technology Company which focuses on vision based human machine interfaces. Formed in 2000 in CanberraAustralia, Seeing Machines purpose is to commercialize its computer-vision across a range of industries and applications. 

Seeing Machines delivers advanced computer vision solutions for researchers and developers in human factors, transportation safety, entertainment, computer human interaction, robotics and medical research. 

Seeing Machines computer vision systems are able to measure the orientation and position of a human head, estimate eye-gaze direction, detect eye blinks and track other facial features. This functionality is achieved entirely though visual means, using video cameras connected to advanced image processing software, with no attachments required on the subject. The faceAPI® product encapsulates the core of Seeing Machines computer-vision algorithms into a package designed for licensing to OEM's and third-parties.

The flagship product faceLAB® provides an automated and contact-free gaze and head tracking technology, it solves the problem of observing human behaviour naturally, non-intrusively and with a high degree of accuracy and usability. Building on these unique face tracking and pupil measurement and monitoring capabilities, the TrueField Analyzer® is new medical device to assist clinicians detect and manage eye diseases such as glaucoma.

The TrueField Analyzer® offers a new objective method to help doctors diagnose and manage a range of eye diseases including glaucoma, age related macular degeneration and diabetic retinopathy. Glaucoma affects about 2-3% of the population over 40 years of age and is a leading source of blindness. Unlike most other devices available to the clinician the TrueField Analyzer is a completely objective test and it is quick and easy for patients and technicians alike. The device measures both eyes concurrently and due to the reliability that arises from the objective nature of the test, it has the potential to become a new standard in the measurement of visual field defects and thus in the diagnosis and management of disease such as glaucoma.

The Driver State Sensor is driver monitoring software targeted at the detection of fatigue and distraction in drivers and operators. The DSS detects drowsiness (fatigue) or that the driver is distracted and their attention has been diverted from the road, alarms are raised to alert the driver to these events. In larger deployments, such as in fleet and mining equipment operations, the data is available in both real-time and off-line modes for fleet management, driver training and awareness programs

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORFKOKNOBKKACD
Date   Source Headline
6th Apr 20232:45 pmRNSDirector/PDMR Shareholding
5th Apr 20239:08 amRNSPDMR Shareholding
31st Mar 202312:26 pmRNSPDMR Shareholding
29th Mar 202311:55 amRNSDirector/PDMR Shareholding
28th Mar 202311:28 amRNSPDMR Shareholding
27th Mar 202310:12 amRNSDirector/PDMR Shareholding
27th Mar 202310:07 amRNSDirector/PDMR Shareholding
24th Mar 202311:56 amRNSPDMR Shareholding
24th Mar 20238:59 amRNSDirector/PDMR Shareholding
22nd Mar 20239:16 amRNSPDMR Shareholding
17th Mar 20239:03 amRNSDirector/PDMR Shareholding
16th Mar 202311:12 amRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPDMR Shareholding
14th Mar 20237:00 amRNSPDMR Shareholding
13th Mar 20239:24 amRNSNo exposure to Silicon Valley Bank
9th Mar 20236:09 pmRNSDirector/PDMR Shareholding
8th Mar 20233:33 pmRNSDirector/PDMR Shareholding
8th Mar 20233:30 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSHalf year results and financial report
22nd Feb 20237:00 amRNSHalf year trading update and quarterly KPIs
15th Feb 20237:00 amRNSNotice of Results & Investor Presentation
8th Feb 20239:46 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSSeeing Machines and Mobileye to target Aftermarket
26th Jan 20239:36 amRNSDirector/PDMR Shareholding
25th Jan 202310:24 amRNSDirector/PDMR Shareholding
16th Jan 202310:28 amRNSDirector/PDMR Shareholding
13th Jan 20238:50 amRNSDirector/PDMR Shareholding
12th Jan 202310:05 amRNSDirector/PDMR Shareholding
11th Jan 202311:19 amRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSLaunch of Silicon Platform with OMNIVISION
4th Jan 20237:00 amRNSThree Collaborations to be showcased at CES 2023
3rd Jan 20237:00 amRNSSeeing Machines to exhibit DMS & OMS at CES 2023
22nd Dec 20227:02 amRNSSeeing Machines awarded additional OEM program
7th Dec 20229:01 amRNSPDMR Shareholding
6th Dec 20228:58 amRNSPDMR Shareholding
5th Dec 20227:00 amRNSPDMR Shareholding
2nd Dec 20227:00 amRNSPDMR Shareholding
29th Nov 20223:31 pmEQSSeeing Machines CEO talks new performance indicators and focus on annual growth
29th Nov 202210:43 amRNSPDMR Shareholding
28th Nov 20228:53 amRNSResult of AGM
24th Nov 202212:43 pmRNSPDMR Shareholding
23rd Nov 20227:00 amRNSKey Performance Indicators Q1 FY 2023
21st Nov 202211:46 amRNSPDMR Shareholding
18th Nov 20227:00 amRNSPDMR Shareholding
16th Nov 20227:00 amRNSPDMR Shareholding
14th Nov 20227:00 amRNSPDMR Shareholding
11th Nov 20227:00 amRNSAppointment of Chief Financial Officer
1st Nov 202211:17 amRNSDirector/PDMR Shareholding
27th Oct 20228:18 amRNSNotice of AGM
27th Oct 20227:00 amRNSYear End Results – FY2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.